Richard Naylor, DO
Orthopaedic Surgery · Waterloo, IANPI 1750317756
Payments from drug & device makers
Across 66 payments — averaging $25.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$416
- Stryker$287
- Next Science LLC$161
- Smith+Nephew$144
- Pacira Therapeutics, Inc.$126
- Bioventus LLC$83
- plus $474 from 20 others
What the payments were for
- Food & beverage$1,691100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $416 |
| Stryker | 9 | $287 |
| Next Science LLC | 2 | $161 |
| Smith+Nephew | 3 | $144 |
| Pacira Therapeutics, Inc. | 6 | $126 |
| Bioventus LLC | 4 | $83 |
| Ferring Pharmaceuticals Inc. | 4 | $68 |
| Axogen | 1 | $43 |
| Pfizer | 3 | $38 |
| Vertex | 2 | $32 |
| FX Shoulder Solutions, Inc | 1 | $30 |
| Zimmer Biomet | 2 | $28 |
| Radius Health, Inc. | 1 | $27 |
| Encore Medical, LP | 1 | $22 |
| Sonex Health, Inc. | 1 | $20 |
| Heraeus Medical, LLC. | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Amgen | 1 | $19 |
| Biomerieux Inc | 1 | $18 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Solventum Corporation | 1 | $14 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $4 |
How this compares
$1,691 in reported general payments places this provider in the 45th percentile of 219 orthopaedic surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 213 | $6,337 |
| Meloxicam | 304 | $1,552 |
| Nabumetone | 20 | $428 |
| Tramadol Hcl | 21 | $133 |
| Amoxicillin | 145 | $129 |
| Clindamycin Hcl | 57 | $84 |
| Ciprofloxacin Hcl | 12 | $58 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $49 |
| Prednisone | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Waterloo
- Jay GintherWaterloo$15K
- Mark GorscheWaterloo$10K
- John CallaghanIowa City$23.3M
- Cesar de Cesar NettoIowa City$905K
- Brian AdamsIowa City$868K
- Lynn NelsonBelmond$285K
- Robert WestermannIowa City$216K
- Jacob ElkinsIowa City$188K
- Brendan PattersonIowa City$166K
- Joseph BuckwalterIowa City$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.